2XE5 | pdb_00002xe5

Molecular insights into clinically isolated OmpC mutants and their role in multi-drug resistance (OmpC26)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.28 Å
  • R-Value Free: 
    0.267 (Depositor), 0.271 (DCC) 
  • R-Value Work: 
    0.226 (Depositor), 0.233 (DCC) 
  • R-Value Observed: 
    0.228 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 2XE5

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Altered Antibiotic Transport in Ompc Mutants Isolated from a Series of Clinical Strains of Multi-Drug Resistant E. Coli.

Lou, H.Chen, M.Black, S.S.Bushell, S.R.Ceccarelli, M.Mach, T.Beis, K.Low, A.S.Bamford, V.A.Booth, I.R.Bayley, H.Naismith, J.H.

(2011) PLoS One 6: 25825

  • DOI: https://doi.org/10.1371/journal.pone.0025825
  • Primary Citation Related Structures: 
    2XE1, 2XE2, 2XE3, 2XE5, 2XG6

  • PubMed Abstract: 

    Antibiotic-resistant bacteria, particularly gram negative species, present significant health care challenges. The permeation of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate). We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins may modulate antibiotic passage through the outer membrane.


  • Organizational Affiliation
    • Centre for Biomolecular Sciences, University of St Andrews, St Andrews, United Kingdom.

Macromolecule Content 

  • Total Structure Weight: 236.02 kDa 
  • Atom Count: 17,072 
  • Modeled Residue Count: 2,058 
  • Deposited Residue Count: 2,058 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
OUTER MEMBRANE PORIN C
A, B, C, D, E
A, B, C, D, E, F
343Escherichia coliMutation(s): 0 
Membrane Entity: Yes 
UniProt
Find proteins for Q9K597 (Escherichia coli)
Explore Q9K597 
Go to UniProtKB:  Q9K597
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9K597
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 9 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
C8E

Query on C8E



Download:Ideal Coordinates CCD File
G [auth A],
KA [auth D],
V [auth B]
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE
C16 H34 O5
FEOZZFHAVXYAMB-UHFFFAOYSA-N
OES

Query on OES



Download:Ideal Coordinates CCD File
LA [auth D],
W [auth B]
N-OCTYL-2-HYDROXYETHYL SULFOXIDE
C10 H22 O2 S
IRJUEMKMQDEOTQ-CYBMUJFWSA-N
D12

Query on D12



Download:Ideal Coordinates CCD File
FA [auth C]
I [auth A]
RA [auth E]
SA [auth E]
TA [auth E]
FA [auth C],
I [auth A],
RA [auth E],
SA [auth E],
TA [auth E],
XA [auth F]
DODECANE
C12 H26
SNRUBQQJIBEYMU-UHFFFAOYSA-N
ASZ

Query on ASZ



Download:Ideal Coordinates CCD File
U [auth B]2-(DIMETHYLAMINO)ETHANESULFONIC ACID
C4 H11 N O3 S
CFAFEJHONLMPQY-UHFFFAOYSA-N
D10

Query on D10



Download:Ideal Coordinates CCD File
O [auth B]
P [auth B]
Q [auth B]
R [auth B]
S [auth B]
O [auth B],
P [auth B],
Q [auth B],
R [auth B],
S [auth B],
T [auth B]
DECANE
C10 H22
DIOQZVSQGTUSAI-UHFFFAOYSA-N
OCT

Query on OCT



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
CA [auth B]
GA [auth C]
J [auth A]
AA [auth B],
BA [auth B],
CA [auth B],
GA [auth C],
J [auth A],
MA [auth D],
N [auth A],
NA [auth D],
UA [auth E],
YA [auth F]
N-OCTANE
C8 H18
TVMXDCGIABBOFY-UHFFFAOYSA-N
HP6

Query on HP6



Download:Ideal Coordinates CCD File
PA [auth D],
WA [auth F],
Y [auth B]
HEPTANE
C7 H16
IMNFDUFMRHMDMM-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
AB [auth F]
HA [auth C]
K [auth A]
L [auth A]
OA [auth D]
AB [auth F],
HA [auth C],
K [auth A],
L [auth A],
OA [auth D],
ZA [auth F]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
HEX

Query on HEX



Download:Ideal Coordinates CCD File
DA [auth C]
EA [auth C]
H [auth A]
IA [auth C]
JA [auth C]
DA [auth C],
EA [auth C],
H [auth A],
IA [auth C],
JA [auth C],
M [auth A],
QA [auth E],
VA [auth F],
X [auth B],
Z [auth B]
HEXANE
C6 H14
VLKZOEOYAKHREP-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.28 Å
  • R-Value Free:  0.267 (Depositor), 0.271 (DCC) 
  • R-Value Work:  0.226 (Depositor), 0.233 (DCC) 
  • R-Value Observed: 0.228 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 74.18α = 98.74
b = 93.68β = 108.79
c = 115.91γ = 109.71
Software Package:
Software NamePurpose
REFMACrefinement
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2010-05-26
    Type: Initial release
  • Version 1.1: 2011-11-16
    Changes: Database references, Version format compliance
  • Version 1.2: 2023-12-20
    Changes: Data collection, Database references, Derived calculations, Other, Refinement description